Get started
MODERNA INCMODERNA INCMODERNA INC

MODERNA INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0QF trade ideas

MRNA Moderna vs PFE Pfizer | Head and Shoulders patternIf you haven`t longed Moderna with me from here: Then you should realize that the head an shoulders pattern on descending volume of a company that worth 53.402B, but has 747Mil negative earnings for 2020, may lead to $100 per share. On the other hand, undervalued, it`s Pfizer , which has the same amazing results with the vaccine, lots of medicine in the portfolio, a market cap almost 4 times higher, 198.973B and positive earnings of 9.62Bil. The pay also great dividends, btw, 4.38% DIV YIELD on a decent 20.82 P/E ratio . If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:MRNAShort
by TopgOptions
8
MRNA Upside PotentialModerna has been forming a hidden bullish divergence for the past 5 months (clearly seen on the daily chart, will also post a screenshot in the comments). On the macro-level, we can see a pennant forming with strongly confirmed resistance and support. On the micro-level, we have a clear cup and handle, and currently the price seats at the support of the handle, in 3h demand, and also at a strong key level 135-136, that MRNA always reacted to in the past. If Moderna confirms the cup and handle by breaking the resistance, would love to add to my long position. However, if it can not hold 135-136, will look to exit and reenter at the macro support ~129. *The idea above is my own opinion and does not serve as any kind of investment advice. Please do your own due diligence.*
NASDAQ:MRNALong
by CodrinTrades
4
MRNA - IN WAVE B CORRECTION PHASE - OVERALL BEARISHMRNA, is currently undergoing correction phase. To be specific, the prices are forming counterwaves ABC of smaller degree (red labelling of ABC) as part of higher degree of Wave B (black labelling) formation. It is predicted the higher degree of Wave B will end at around USD163 before making bigger downtrend movement of Wave C. The target for Wave C is to hit minimal of around USD79 (61.8% FIBO correction), or to the worst of around USD49.6 (78.6% FIBO correction). A stock of potential shorting opportunities on rebound. Happy trading.
NASDAQ:MRNA
by AmazeOptions
9
HERCULES portfolio: weekly course valuationHERCULES’ mid-term trend chart is presented. Also the mid-term trend charts of the stocks that make up the portfolio are presented. ___ Comments on the chart: --------------------------------- * Eventually the rising reaction (totally 21%) stopped at the strong resistance of the 50d SMA. * This rising reaction was a very good chance to sell in the highest possible (this time period) prices. * Here I want to stress, for the new traders, that when a stock's price falls -10,00% needs +11,11% rise to comeback. If it falls -20,00% needs +25,00%, -30,00% needs +42,86%, -50,00% needs +100,00%, -80,00% needs +400,00% and -90,00% needs +900,00%. Do the math in ECXEL right now to see how it goes! * Most of the new traders discover the previous disappointing percentages only when it's too late. * You must stop the losses when they are relatively small and manageable. That is up to 20%. From this point and further, the bigger the losses the more difficult to comeback. For example, if you lose 50% of your capital, in a bear market it's practically impossible to succeed 100% gains to go even. * Now the portfolio's price is under the 9d SMA again and it's probable that a "head and shoulders" pattern (with an atrophic right shoulder) will be formed and the fall will continue stronger. * In general, we still remain very cautious and closely monitor the market in the coming days, because many index-heavy stocks are close to critical support levels that if they break down, will cause panic and a sharp decline. * This HERCULES' portfolio analysis and all the previous ones, apply to all the portfolios with popular Nasdaq stocks and the new traders should follow these analyses, because they are an application of the method described in my post "You can't beat the market", until they don't need these analyses anymore because they'll do their own. ------------------------------------------------------------------------------------------------------------------- * The right opinion is difficult * Many words do not reveal a profound point of view THALES OF MILETUS (Greek philoshopher) Thales (624-547 BC) is the oldest prosocratic philosopher, the first of the seven sages of antiquity ------------------------------------------------------------------------------------------------------------------- Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:MRNA
by Gnothisafton
HERCULES portfolio: weekly course valuationHERCULES’ mid-term trend chart is presented. Also the mid-term trend charts of the stocks that make up the portfolio are presented. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here. A copy of the text on the chart follows: --------------------------------------------------- HERCULES portfolio: weekly course valuation 15.6% rebound * In my previous week's portfolio valuation I mentioned that a rising reaction was probable and that it should be considered as a chance to sell in higher prices. I noted also that this guideline will change only if the prices cross upwards the 30d, 50d and the 200d SMAs. * Notice that as soon as the RSI reached its oversold area we had a rising reaction of 15.6%. However, the MACD (which is in negative area) has not yet crossed its signal upwards. * If the portfolio price overcomes the resistance zone R and remain for 2-3 days over the 30d SMA then we have to buy back the stocks that will follow this move (if their price is over the 200d SMA too). * If the portfolio price fails to brake the strong resistance zone R then a sharp fall (even with a gap) is probable. * With the exception of ERIC, all the other stock prices of the initial portfolio (MRNA, INO, ZM, HFG and CRSR) are below both the 30d and the 50d SMAs. INO's and ZM's price is below the 200d SMA too. CRSR's price is below the 200(10h) SMA (the 200d SMA is not yet defined because it's a recent IPO). * In general, we remain very cautious and closely monitor the market in the coming days, because many index-heavy stocks are close to critical support levels that if they break down, will cause panic and a sharp decline. * This HERCULES' portfolio analysis and all the previous ones, apply to all the portfolios with popular Nasdaq stocks and the new traders should follow these analyses, because they are an application of the method described in my post "You can't beat the market", until they don't need these analyses anymore because they'll do their own. ------------------------------------------------------------------------------------------------------------------------------ It's difficult to know yourself It's easy to give advice to another THALES OF MILETUS (Greek philoshopher)
NASDAQ:MRNA
by Gnothisafton
HERCULES portfolio: weekly course valuationHERCULES’ mid-term trend chart is presented. Also the mid-term trend charts of the stocks that make up the portfolio are presented. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
NASDAQ:MRNAShort
by Gnothisafton
2